Robuta

Scientists are developing a therapeutic vaccine that educates the patient's immune system to identify and destroy cancer cells.

The Covid-19 vaccine can boost the immune system during immunotherapy, leading to better outcomes for cancer patients.

New research in the journal Science Translational Medicine shows that helper T cells could play a crucial role in a bold and complex new strategy for making an...

HPV can cause a variety of cancers, including cervical. New mortality data for women under 25 point to the success of the HPV vaccine.

The Cancer Vaccine Institute at UW Medicine strives to create a world where cancer can be managed, treated, and ultimately prevented by vaccines and...

GAINESVILLE, Fla. — An experimental mRNA vaccine boosted the tumor-fighting effects of immunotherapy in a mouse-model study, bringing researchers one step…

Oct 17, 2025

Oct 23, 2025 - Some COVID-19 vaccines could help cancer patients live longer by helping the immune system fight tumours, a...

*ProscaVax is currently in clinical trials and not available to the general public. ProscaVax has not received U.S. Food and Drug Administration approval and...

Nine sub-types of the human papillomavirus are responsible for 85 per cent of pre-cancerous cells of the cervix. A new vaccine could now prevent these...

Over 135 million doses have been given in the U.S., and studies show mostly mild side effects, like a sore arm, and no increase in serious health risks

One dose of human papillomavirus (HPV) vaccine was highly effective in protecting against infection from HPV 16 and 18, the KEN SHE study in Kenya found.

A federal vaccine advisory panel has voted to recommend a second vaccine against cervical cancer for girls and young women.

May 16, 2025 - In the U.S., HPV infections are estimated to cause about 37,300 cases of cancer. The HPV vaccine can prevent over 90% of these cancers from ever developing.

The promising new lung cancer treatment builds on the research that went into developing coronavirus vaccines during the pandemic.

New Phase 1 data from Memorial Sloan Kettering Cancer Center shows an investigational cancer vaccine may elicit lasting immune response in patients with...

The FDA last week approved two vaccines for the prevention of human papillomavirus (HPV), which can lead to cervical cancer, genital warts and various genital...

HPV vaccine safe and reduces risk of cervical cancer, anti-misinformation review finds

Feb 20, 2025 - A cancer vaccine will be available to women within a few months in India, Union Minister of State for Health, Family Welfare and Ayush Prataprao Jadhav...

May 9, 2025 - The V Foundation and the Cancer Vaccine Coalition (CVC) have joined forces to fund the development of therapeutic breast cancer vaccines—a promising new

An ambitious November campaign to protect a million girls with the HPV vaccine could mark a historic inflection point in Sierra Leone’s journey to...

An ambitious November campaign to protect a million girls with the HPV vaccine could mark a historic inflection point in Sierra Leone’s journey to...

When researchers offer data suggesting a personalized vaccine might be able to keep the cancer at bay for years, it’s worth paying attention to.

Fear of side effects, lack of direction from their doctor and the notion that prior infection means you don't need the vaccine are among the top reasons cancer...

The fight against hereditary cancer has long been a reactive battle waged with scalpels and surveillance, but a landmark clinical trial now suggests a future...

Jun 14, 2023 - Researchers from Tel Aviv University and Sheba Hospital believe that the new discovery may contribute to the development of a vaccine against melanoma.

Widespread HPV vaccine use dramatically reduces the number of women who will develop cervical cancer, a large study has shown. In the study of nearly 1.7...

A landmark study finds that cancer patients receiving immune checkpoint inhibitors were twice as likely to survive three years if they received an mRNA...

From COVID-19 to the seasonal flu and RSV, vaccinations for respiratory viruses are typically delivered via intramuscular injection, which generates antibodies...